Thursday, August 31, 2023
GEDiCube, a medical technology startup, has announced its partnership with NVIDIA Inception, a program that aids startups by providing access to state-of-the-art technology, technical support, and venture capital. The collaboration aims to further GEDiCube's mission of early cancer detection.
Craig Rhodes, CEO of GEDiCube, expressed excitement about the partnership, highlighting its alignment with the company's objectives. He emphasized the synergy between NVIDIA's advanced medical imaging capabilities and GEDiCube's existing multi-omic AI system. The goal is to develop an algorithm that leverages both imaging and omic data for a comprehensive analysis, enabling more accurate cancer assessments.
The plan involves deploying GEDiCube's multi-omic platform through NVIDIA's accelerated infrastructure, utilizing the Medical Imaging Open Network for Artificial Intelligence (MONAI). This innovative approach could potentially transform early pancreatic cancer detection. The company intends to apply this multi-modal technique in an upcoming clinical trial. The trial will incorporate MONAI to detect and establish a predictive model based on tumor size, supplemented by the multi-omic platform's insights into tumor type.
GEDiCube's strategy addresses a critical challenge in combatting cancers like pancreatic cancer, which often evade detection until advanced stages, leading to unfavorable outcomes. By employing artificial intelligence to analyze diverse datasets, GEDiCube aims to enhance the efficiency and effectiveness of clinical trials, opening new avenues for tackling these formidable diseases.
NVIDIA Inception's support plays a pivotal role in GEDiCube's product development, prototyping, and deployment stages. The program offers a range of benefits to its members, including NVIDIA Deep Learning Institute credits, exclusive pricing for NVIDIA hardware and software, and technological guidance. These resources equip startups like GEDiCube with essential tools to foster innovation and growth.